Get the Stockscreener App
1.19
11.21%
0.12
After Hours:
1.19
Lexaria Bioscience Corp stock is traded at $1.19, with a volume of 350.50K.
It is up +11.21% in the last 24 hours and up +42.77% over the past month.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
See More
Previous Close:
$1.07
Open:
$1.09
24h Volume:
350.50K
Relative Volume:
2.08
Market Cap:
$23.28M
Revenue:
$411.00K
Net Income/Loss:
$-4.85M
P/E Ratio:
-2.7045
EPS:
-0.44
Net Cash Flow:
$-4.88M
1W Performance:
+15.53%
1M Performance:
+42.77%
6M Performance:
-17.36%
1Y Performance:
-66.19%
1-Day Range:
$1.06
$1.34
1-Week Range:
$0.97
$1.34
52-Week Range:
$0.7749
$3.565
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Name
Lexaria Bioscience Corp
Sector
Industry
Phone
250-765-6424
Address
100 - 740 MCCURDY ROAD, KELOWNA
Compare LEXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.19 | 19.75M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp Stock (LEXX) Latest News
Chart based analysis of Lexaria Bioscience Corp. trendsWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser
Can Lexaria Bioscience Corp. Equity Warrant hit a new high this monthMarket Growth Summary & Real-Time Volume Trigger Notifications - Newser
Real time scanner hits for Lexaria Bioscience Corp. explained2025 AllTime Highs & Verified Chart Pattern Trade Signals - Newser
Multi asset correlation models including Lexaria Bioscience Corp.July 2025 EndofMonth & Reliable Price Action Trade Plans - Newser
Will Lexaria Bioscience Corp. Equity Warrant see short term momentumMarket Trend Review & Smart Swing Trading Alerts - Newser
Published on: 2025-09-12 17:52:14 - Newser
Identifying reversal signals in Lexaria Bioscience Corp. Equity Warrant2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
Should you hold or exit Lexaria Bioscience Corp. nowJuly 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Using RSI to spot recovery in Lexaria Bioscience Corp.Earnings Miss & Free Reliable Trade Execution Plans - Newser
Published on: 2025-09-12 13:51:40 - Newser
Using AI based signals to follow Lexaria Bioscience Corp.Share Buyback & Free Reliable Trade Execution Plans - Newser
What institutional flow reveals about Lexaria Bioscience Corp. Equity Warrant2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Can momentum traders help lift Lexaria Bioscience Corp.Take Profit & Weekly High Potential Alerts - Newser
Is Lexaria Bioscience Corp. trending in predictive chart modelsJuly 2025 Gainers & Consistent Growth Equity Picks - Newser
Combining price and volume data for Lexaria Bioscience Corp.Risk Management & Expert Approved Momentum Trade Ideas - Newser
Can machine learning forecast Lexaria Bioscience Corp. recoveryBear Alert & Safe Capital Growth Tips - Newser
Analyzing Lexaria Bioscience Corp. Equity Warrant with multi timeframe chartsTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Will Lexaria Bioscience Corp. stock recover after recent dropJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser
Backtesting results for Lexaria Bioscience Corp. Equity Warrant trading strategiesQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
Comparing Lexaria Bioscience Corp. in custom built stock radarsMarket Activity Report & Daily Oversold Bounce Ideas - Newser
Advanced analytics toolkit walkthrough for Lexaria Bioscience Corp. Equity WarrantLong Setup & Fast Gain Swing Trade Alerts - Newser
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference - Investing News Network
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone - Investing News Network
Will Lexaria Bioscience Corp. Equity Warrant rebound enough to break evenWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
Applying Elliott Wave Theory to Lexaria Bioscience Corp.2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
What recovery options are there for Lexaria Bioscience Corp.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Real time scanner hits for Lexaria Bioscience Corp. Equity Warrant explained - Newser
Lexaria Bioscience Corp.’s volatility index tracking explainedQuarterly Profit Report & Real-Time Volume Analysis - Newser
Full technical analysis of Lexaria Bioscience Corp. stockEarnings Performance Report & Reliable Breakout Forecasts - Newser
Using R and stats models for Lexaria Bioscience Corp. Equity Warrant forecasting2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
What Fibonacci levels say about Lexaria Bioscience Corp. rebound2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Is it time to cut losses on Lexaria Bioscience Corp.Market Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Combining price and volume data for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Market Mood & Safe Entry Momentum Tips - Newser
What earnings revisions data tells us about Lexaria Bioscience Corp. Equity Warrant2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Has Lexaria Bioscience Corp. Equity Warrant formed a bullish divergenceInsider Buying & Expert-Curated Trade Recommendations - Newser
Relative strength of Lexaria Bioscience Corp. Equity Warrant in sector analysisEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Using Bollinger Bands to evaluate Lexaria Bioscience Corp.Weekly Trend Report & Low Risk High Reward Trade Ideas - Newser
Is a relief rally coming for Lexaria Bioscience Corp. holdersJuly 2025 Analyst Calls & Weekly High Momentum Picks - Newser
Leading vs lagging indicators on Lexaria Bioscience Corp. performanceDip Buying & Intraday High Probability Setup Alerts - Newser
Will Lexaria Bioscience Corp. Equity Warrant outperform tech stocksPortfolio Performance Summary & Growth Oriented Trade Recommendations - Lancaster City Council
Is it too late to sell Lexaria Bioscience Corp.Weekly Risk Report & Stock Market Timing Techniques - Newser
Lexaria Bioscience Corp Stock (LEXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):